• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • Clinical Trial Listings
    • What are Clinical Trials?
    • Become a Clinical Trial Volunteer
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Market Research
    • Benchmark Reports
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
  • White Papers
  • Clinical Trial Listings
  • Advertise
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Pipeline

Pipeline

June 21, 2021
Company Drug/Device Medical Condition Status
Asieris Pharmaceuticals APL-1202 in combination with BeiGene's tislelizumab neoadjuvant therapy in patients with muscle-invasive bladder cancer IND approved by the FDA
ImmunityBio Anktiva in combination with standard chemotherapy and Trodelvy (sacituzumab govitecan-hziy) advanced triple-negative breast cancer IND approved by the FDA
Oryzon Therapeutics vafidemstat borderline personality disorder IND approved by the FDA for phase 2b trial
Xilio Therapeutics XTX101 solid tumors IND approved by the FDA
Siranomics STP705 skin squamous-cell carcinoma in situ IND approved by China’s National Medical Product Administration
LivaNova aura6000 System, implantable hypoglossal neurostimulator moderate-to-severe obstructive sleep apnea in adults Investigational Device Exemption approved by the FDA
Quidel Sofia Q rapid antigen test device Emergency Use Authorization granted by the FDA
Blueprint Medicines Ayvakit (avapritinib) advanced systemic mastocytosis (SM), including aggressive SM and SM with an associated hematological neoplasmand mast-cell leukemia approved by the FDA
Eton Pharmaceuticals Rezipres (ephedrine hydrochloride injection) hypotension occurring in the setting of anesthesia approved by the FDA
Gilead Sciences Epclusa (sofosbuvir/velpatasvir) chronic hepatitis C in children as young as three years regardless of HCV genotype or liver disease severity approved by the FDA for new formulation
AVITA Medical Recell System in combination with meshed autografting treatment of all sizes of acute full-thickness thermal burn wounds for both pediatrics and adults approved by the FDA for expanded use
Neo Medical

Osartis
Neo Pedicle Screw System in combination with BonOs Inject cement compromised bone quality in late-stage tumors approved by the FDA
Stratatech StrataGraft deep partial-thickness burns approved by the FDA

 

    Upcoming Events

    • 05Dec

      Thriving in Clinical Research – Overcoming Common Challenges as a Site: Part 3 – Site Resourcing

    • 14Apr

      MAGI 2024: The Clinical Research Conference

    Featured Products

    • Surviving an FDA GCP Inspection

      Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

    • Best Practices for Clinical Trial Site Management

      Best Practices for Clinical Trial Site Management

    Featured Stories

    • Jonathan Seltzer

      Thought Leadership: Remote Patient Monitoring Gives New View of Safety in Cardiac Clinical Trials

    • Quality_Compass-360x240.png

      Ask the Experts: Applying Quality by Design to Protocols

    • Obesity Treatment Patient

      Clinical Trials Need Greater Representation of Obese Patients, Experts Say

    • Modernize-360x240.png

      FDA IT Modernization Plan Prioritizes Data-Sharing, AI, Collaboration and More

    Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

    The information you need to adapt your monitoring plan to changing times.

    Learn More Here
    • About Us
    • Contact Us
    • Privacy Policy
    • Do Not Sell or Share My Data

    Footer Logo

    300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

    Phone 703.538.7600 – Toll free 888.838.5578

    Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing